None
Quote | Iterum Therapeutics plc (NASDAQ:ITRM)
Last: | $1.15 |
---|---|
Change Percent: | 1.79% |
Open: | $1.1 |
Close: | $1.15 |
High: | $1.1899 |
Low: | $1.1 |
Volume: | 99,202 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Iterum Therapeutics plc (NASDAQ:ITRM)
2024-06-21 12:37:40 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q1 2024 Earnings Call Transcript Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript Iterum Therapeutics Non-GAAP EPS of -$0.38 beats by $0.16 Iterum Therapeutics re...
DUBLIN, Ireland and CHICAGO, June 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
Message Board Posts | Iterum Therapeutics plc (NASDAQ:ITRM)
Subject | By | Source | When |
---|---|---|---|
Interesting his $ITRM release info about its drugs | pillskill | investorshub | 04/25/2023 5:37:30 PM |
Every day we're a little closer to FDA approval. | velcro | investorshub | 04/14/2023 11:42:00 PM |
$ITRM some Insider Buying showing up ! | swanlinbar | investorshub | 04/13/2023 4:20:21 PM |
$ITRM >Iterum Therapeutics Reports Fourth Quarter and Full | swanlinbar | investorshub | 03/21/2023 3:47:53 PM |
All niotech went up. And same reset. Its | Harbor6460 | investorshub | 03/01/2023 12:36:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Iterum Therapeutics plc Website:
DUBLIN, Ireland and CHICAGO, June 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
DUBLIN and CHICAGO, June 05, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hosp...
DUBLIN and CHICAGO, May 31, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospi...